K. Klespe

Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study

M. Heppt, R. Dummer, L. Heinzerling, 2023, Cancers.

Real‐world outcomes using PD‐1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland

S. Haferkamp, K. Kähler, W. Peitsch, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Altersekzeme und deren Therapie

T. Werfel, S. Traidl, K. Klespe, 2023, Die Dermatologie.